Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-13-055051
Filing Date
2013-12-03
Accepted
2013-12-03 18:04:36
Documents
1
Period of Report
2013-12-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4157
  Complete submission text file 0001209191-13-055051.txt   5559
Mailing Address 12555 HIGH BLUFF DRIVE SUITE 385 San Diego CA 92130
Business Address 12555 HIGH BLUFF DRIVE SUITE 385 San Diego CA 92130 (760) 487-1255
Evoke Pharma Inc (Issuer) CIK: 0001403708 (see all company filings)

EIN.: 208447886 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O EVOKE PHARMA, INC. 12555 HIGH BLUFF DR., SUITE 385 SAN DIEGO CA 92130
Business Address
CARLSON MARILYN R. (Reporting) CIK: 0001592848 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36075 | Film No.: 131255477